Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : firstname.lastname@example.org
|Drug Name||Octreotide acetate|
|Trade Name||Sandostatin Lar Depot|
Sandostatin Lar Depot (octreotide acetate) mimics the activity of somatostatin, inhibiting growth hormone, glucagon, and insulin, decreasing LH response to gonadotropin-releasing hormone, decreasing splanchnic blood flow, and inhibiting the release of serotonin, gastrin, vasoactive intestinal peptide, secretin, motilin, pancreatic polypeptide, and thyroid stimulating hormone (NCI Drug Dictionary).
|Therapy Name||Drugs||Efficacy Evidence||Clinical Trials|
|Cixutumumab + Everolimus + Octreotide acetate||Cixutumumab Everolimus Octreotide acetate||1||0|
|Everolimus + Octreotide acetate||Everolimus Octreotide acetate||0||1|
|lutetium Lu 177 dotatate + Octreotide acetate||Octreotide acetate lutetium Lu 177 dotatate||0||1|
|Octreotide acetate||Octreotide acetate||0||1|